Boston Scientific
About Boston Scientific
Boston Scientific is a global medical device manufacturer headquartered in Marlborough, Massachusetts, specialising in cardiology, endoscopy, urology and neuromodulation devices.
Leadership Team
Leadership as listed on bostonscientific.com, checked 26 Sep 2026. Details can change; the linked page is the authoritative source.
Jonathan R. Monson
Vance R. Brown
Arthur C. Butcher
Joseph M. Fitzgerald
Products & Services
Products and services as listed on bostonscientific.com, checked 26 Sep 2026. Details can change; the linked page is the authoritative source.
Cardiac Rhythm Management
Technologies to monitor, diagnose and treat irregular heart rhythms, heart failure and sudden cardiac arrest.
Source: bostonscientific.comElectrophysiology
Technologies for diagnosing and treating heart rhythm disorders.
Source: bostonscientific.comEndoscopy
Devices for gastrointestinal and pancreaticobiliary conditions and obesity-related weight loss.
Source: bostonscientific.comInterventional Cardiology & Vascular Therapies
Technologies for patients with heart and vascular conditions.
Source: bostonscientific.comNeuromodulation
Implantable technologies for chronic pain and neurological conditions.
Source: bostonscientific.comUrology
Solutions for kidney stones, BPH, prostate cancer, pelvic health and erectile dysfunction.
Source: bostonscientific.comInterventional Oncology & Embolization
Embolization, cryoablation, Y-90 and related cancer care tools.
Source: bostonscientific.comSites in Ireland
Galway
Principal manufacturing facility at Ballybrit Business Park.
Source: bostonscientific.comClonmel, Co. Tipperary
Principal manufacturing facility on Cashel Road; also listed as an R&D Centre of Excellence.
Source: bostonscientific.comCork
Principal manufacturing facility at the Business and Technology Park, Model Farm Road.
Source: bostonscientific.comSites as listed on bostonscientific.com, checked 26 Sep 2026. Details can change; the linked page is the authoritative source.
Pipeline & Regulatory Record
What public registers list for Boston Scientific: clinical trials it sponsors, FDA device clearances, Irish licences, recent approvals and supply shortages. Rebuilt daily, last on 21 Nov 2026.
Clinical trials 67 in our ClinicalTrials.gov registers
Showing 10 of 67, trials with Irish sites first. The full lists are on the sponsor pages below.
All trials by sponsor name 1 registry name
Drugs in these trials 2 compounds
FDA 510(k) device clearances 5 · 2 to an Irish-based entity
- SpaceOAR Flex™ SystemK262151 · Boston Scientific Corporation · 11 Sep 2026 · Class 2
- Rezum SystemK262460 · Boston Scientific · 3 Sep 2026 · Class 2
- LithoVue Elite Digital Flexible Ureteroscope SystemK261153 · Boston Scientific Corporation · 26 Aug 2026 · Class 2
- Emerge Monorail PTCA Dilatation CatheterK220629 · Boston Scientific, Ireland · 24 Mar 2022 · Class 2
- 2cm Peripheral Cutting Balloon Microsurgical Dilatation CatheterK151253 · Boston Scientific Limited, Ireland · 10 Jun 2015 · Class 2
Clearances in our FDA device register: every clearance to an Irish-based applicant, plus the last 90 days worldwide.
Group (Boston Scientific): founded 1979, headquarters Marlborough, website bostonscientific.com. Wikidata Q894585 · Wikipedia. From Wikidata (CC0), matched by the group's SEC filer number.
How this is matched: register records are linked to this page by the organisation name they carry, here Boston Scientific Corporation; Boston Scientific; Boston Scientific Limited. Spot a wrong match? Tell us.
Financials & Irish Entities
From the annual reports Boston Scientific Corporation files with the US Securities and Exchange Commission (10-K, US GAAP), in USD as reported. Latest financial year: to Dec 2025.
| Year to | Revenue | R&D | R&D % | Net income | Filing |
|---|---|---|---|---|---|
| Dec 2025 | $20.07bn | $2.05bn | 10.2% | $2.89bn | 10-K 2026 |
| Dec 2024 | $16.75bn | $1.62bn | 9.6% | $1.85bn | 10-K 2026 |
| Dec 2023 | $14.24bn | $1.41bn | 9.9% | $1.59bn | 10-K 2026 |
| Dec 2022 | $12.68bn | $1.32bn | 10.4% | $698m | 10-K 2025 |
| Dec 2021 | $11.89bn | $1.20bn | 10.1% | $1.04bn | 10-K 2024 |
R&D is shown as tagged in the filing, which for this company can exclude acquired in-process R&D. Each year is taken from the most recent annual report that includes it, so earlier years reflect any later restatement. Source: SEC EDGAR (XBRL financial data). Compare companies on the pharma company financials register.
Companies registered in Ireland 4 active in the CRO register
| Company | CRO no. | Registered | Last accounts |
|---|---|---|---|
| Boston Scientific Group Limited LTD - Private Company Limited by Shares | 213208 | 1994 | Dec 2025 |
| Boston Scientific Limited LTD - Private Company Limited by Shares | 213232 | 1994 | Dec 2025 |
| Boston Scientific International Finance Limited LTD - Private Company Limited by Shares · LEI K7K3BSJGN6EJ7O3MC496 | 350500 | 2001 | Dec 2025 |
| Boston Scientific Medical Device Limited LTD - Private Company Limited by Shares | 615709 | 2017 | Dec 2025 |
From the Companies Registration Office (CRO Open Data, CC BY 4.0). A company is listed when GLEIF's legal entity register links it to Boston Scientific Corporation as its ultimate parent, or when we checked its name and registered address by hand. Branches of foreign companies appear as "External company". Spot a missing or wrong entry? Tell us.